#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0006]Every year, millions of patients are treated for life-threatening emergencies in the United States.
1-1	0-1	[	_	_	
1-2	1-5	0006	_	_	
1-3	5-6	]	_	_	
1-4	6-11	Every	_	_	
1-5	12-16	year	_	_	
1-6	16-17	,	_	_	
1-7	18-26	millions	_	_	
1-8	27-29	of	_	_	
1-9	30-38	patients	_	_	
1-10	39-42	are	_	_	
1-11	43-50	treated	_	_	
1-12	51-54	for	_	_	
1-13	55-71	life-threatening	_	_	
1-14	72-83	emergencies	_	_	
1-15	84-86	in	_	_	
1-16	87-90	the	_	_	
1-17	91-97	United	_	_	
1-18	98-104	States	_	_	
1-19	104-105	.	_	_	

#Text=Such emergencies include shock, trauma, cardiac arrest, drug overdoses, diabetic ketoacidosis, arrhythmias, burns, and status epilepticus just to name a few.
2-1	106-110	Such	_	_	
2-2	111-122	emergencies	_	_	
2-3	123-130	include	_	_	
2-4	131-136	shock	_	_	
2-5	136-137	,	_	_	
2-6	138-144	trauma	_	_	
2-7	144-145	,	_	_	
2-8	146-153	cardiac	_	_	
2-9	154-160	arrest	_	_	
2-10	160-161	,	_	_	
2-11	162-166	drug	_	_	
2-12	167-176	overdoses	_	_	
2-13	176-177	,	_	_	
2-14	178-186	diabetic	_	_	
2-15	187-199	ketoacidosis	_	_	
2-16	199-200	,	_	_	
2-17	201-212	arrhythmias	_	_	
2-18	212-213	,	_	_	
2-19	214-219	burns	_	_	
2-20	219-220	,	_	_	
2-21	221-224	and	_	_	
2-22	225-231	status	_	_	
2-23	232-243	epilepticus	_	_	
2-24	244-248	just	_	_	
2-25	249-251	to	_	_	
2-26	252-256	name	_	_	
2-27	257-258	a	_	_	
2-28	259-262	few	_	_	
2-29	262-263	.	_	_	

#Text=For example, according to the American Heart Association, more than 1,500,000 patients suffer from heart attacks (myocardial infarctions) every year, with over 500,000 of them dying from its devastating complications.
#Text=[0007]Obtaining satisfactorily vascular access may be a critical problem in approximately five (5%) percent to ten (10%) percent of patients treated in either prehospital or hospital settings.
3-1	264-267	For	_	_	
3-2	268-275	example	_	_	
3-3	275-276	,	_	_	
3-4	277-286	according	_	_	
3-5	287-289	to	_	_	
3-6	290-293	the	_	_	
3-7	294-302	American	_	_	
3-8	303-308	Heart	_	_	
3-9	309-320	Association	_	_	
3-10	320-321	,	_	_	
3-11	322-326	more	_	_	
3-12	327-331	than	_	_	
3-13	332-341	1,500,000	_	_	
3-14	342-350	patients	_	_	
3-15	351-357	suffer	_	_	
3-16	358-362	from	_	_	
3-17	363-368	heart	_	_	
3-18	369-376	attacks	_	_	
3-19	377-378	(	_	_	
3-20	378-388	myocardial	_	_	
3-21	389-400	infarctions	_	_	
3-22	400-401	)	_	_	
3-23	402-407	every	_	_	
3-24	408-412	year	_	_	
3-25	412-413	,	_	_	
3-26	414-418	with	_	_	
3-27	419-423	over	_	_	
3-28	424-431	500,000	_	_	
3-29	432-434	of	_	_	
3-30	435-439	them	_	_	
3-31	440-445	dying	_	_	
3-32	446-450	from	_	_	
3-33	451-454	its	_	_	
3-34	455-466	devastating	_	_	
3-35	467-480	complications	_	_	
3-36	480-481	.	_	_	
3-37	482-483	[	_	_	
3-38	483-487	0007	_	_	
3-39	487-488	]	_	_	
3-40	488-497	Obtaining	_	_	
3-41	498-512	satisfactorily	_	_	
3-42	513-521	vascular	_	_	
3-43	522-528	access	_	_	
3-44	529-532	may	_	_	
3-45	533-535	be	_	_	
3-46	536-537	a	_	_	
3-47	538-546	critical	_	_	
3-48	547-554	problem	_	_	
3-49	555-557	in	_	_	
3-50	558-571	approximately	_	_	
3-51	572-576	five	_	_	
3-52	577-578	(	_	_	
3-53	578-580	5%	_	_	
3-54	580-581	)	_	_	
3-55	582-589	percent	_	_	
3-56	590-592	to	_	_	
3-57	593-596	ten	_	_	
3-58	597-598	(	_	_	
3-59	598-601	10%	_	_	
3-60	601-602	)	_	_	
3-61	603-610	percent	_	_	
3-62	611-613	of	_	_	
3-63	614-622	patients	_	_	
3-64	623-630	treated	_	_	
3-65	631-633	in	_	_	
3-66	634-640	either	_	_	
3-67	641-652	prehospital	_	_	
3-68	653-655	or	_	_	
3-69	656-664	hospital	_	_	
3-70	665-673	settings	_	_	
3-71	673-674	.	_	_	

#Text=In the U.S. approximately six million patients annually may experience problems with traditional intravenous access.
4-1	675-677	In	_	_	
4-2	678-681	the	_	_	
4-3	682-685	U.S	_	_	
4-4	685-686	.	_	_	
4-5	687-700	approximately	_	_	
4-6	701-704	six	_	_	
4-7	705-712	million	_	_	
4-8	713-721	patients	_	_	
4-9	722-730	annually	_	_	
4-10	731-734	may	_	_	
4-11	735-745	experience	_	_	
4-12	746-754	problems	_	_	
4-13	755-759	with	_	_	
4-14	760-771	traditional	_	_	
4-15	772-783	intravenous	_	_	
4-16	784-790	access	_	_	
4-17	790-791	.	_	_	

#Text=An essential element for treating medical emergencies is rapid establishment of vascular access to administer drugs and fluids directly into the circulatory system.
5-1	792-794	An	_	_	
5-2	795-804	essential	_	_	
5-3	805-812	element	_	_	
5-4	813-816	for	_	_	
5-5	817-825	treating	_	_	
5-6	826-833	medical	_	_	
5-7	834-845	emergencies	_	_	
5-8	846-848	is	_	_	
5-9	849-854	rapid	_	_	
5-10	855-868	establishment	_	_	
5-11	869-871	of	_	_	
5-12	872-880	vascular	_	_	
5-13	881-887	access	_	_	
5-14	888-890	to	_	_	
5-15	891-901	administer	_	_	
5-16	902-907	drugs	_	_	
5-17	908-911	and	_	_	
5-18	912-918	fluids	_	_	
5-19	919-927	directly	_	_	
5-20	928-932	into	_	_	
5-21	933-936	the	_	_	
5-22	937-948	circulatory	_	_	
5-23	949-955	system	_	_	
5-24	955-956	.	_	_	

#Text=Whether in an ambulance by paramedics, or in an emergency room by emergency specialists, the goal is the same--administer life-saving drugs and fluids.
6-1	957-964	Whether	_	_	
6-2	965-967	in	_	_	
6-3	968-970	an	_	_	
6-4	971-980	ambulance	_	_	
6-5	981-983	by	_	_	
6-6	984-994	paramedics	_	_	
6-7	994-995	,	_	_	
6-8	996-998	or	_	_	
6-9	999-1001	in	_	_	
6-10	1002-1004	an	_	_	
6-11	1005-1014	emergency	_	_	
6-12	1015-1019	room	_	_	
6-13	1020-1022	by	_	_	
6-14	1023-1032	emergency	_	_	
6-15	1033-1044	specialists	_	_	
6-16	1044-1045	,	_	_	
6-17	1046-1049	the	_	_	
6-18	1050-1054	goal	_	_	
6-19	1055-1057	is	_	_	
6-20	1058-1061	the	_	_	
6-21	1062-1066	same	_	_	
6-22	1066-1067	-	_	_	
6-23	1067-1068	-	_	_	
6-24	1068-1078	administer	_	_	
6-25	1079-1090	life-saving	_	_	
6-26	1091-1096	drugs	_	_	
6-27	1097-1100	and	_	_	
6-28	1101-1107	fluids	_	_	
6-29	1107-1108	.	_	_	

#Text=To a large degree, the ability to successfully treat such critical emergencies is dependent on skill and luck of an operator in accomplishing vascular access.
#Text=[0008]While it is relatively easy to start an IV on many patients, doctors, nurses and paramedics often experience great difficulty establishing IV access in some patients.
7-1	1109-1111	To	_	_	
7-2	1112-1113	a	_	_	
7-3	1114-1119	large	_	_	
7-4	1120-1126	degree	_	_	
7-5	1126-1127	,	_	_	
7-6	1128-1131	the	_	_	
7-7	1132-1139	ability	_	_	
7-8	1140-1142	to	_	_	
7-9	1143-1155	successfully	_	_	
7-10	1156-1161	treat	_	_	
7-11	1162-1166	such	_	_	
7-12	1167-1175	critical	_	_	
7-13	1176-1187	emergencies	_	_	
7-14	1188-1190	is	_	_	
7-15	1191-1200	dependent	_	_	
7-16	1201-1203	on	_	_	
7-17	1204-1209	skill	_	_	
7-18	1210-1213	and	_	_	
7-19	1214-1218	luck	_	_	
7-20	1219-1221	of	_	_	
7-21	1222-1224	an	_	_	
7-22	1225-1233	operator	_	_	
7-23	1234-1236	in	_	_	
7-24	1237-1250	accomplishing	_	_	
7-25	1251-1259	vascular	_	_	
7-26	1260-1266	access	_	_	
7-27	1266-1267	.	_	_	
7-28	1268-1269	[	*[1]	8-14[2_1]	
7-29	1269-1273	0008	*[1]	_	
7-30	1273-1274	]	*[1]	_	
7-31	1274-1279	While	*[1]	_	
7-32	1280-1282	it	*[1]	_	
7-33	1283-1285	is	*[1]	_	
7-34	1286-1296	relatively	*[1]	_	
7-35	1297-1301	easy	*[1]	_	
7-36	1302-1304	to	*[1]	_	
7-37	1305-1310	start	*[1]	_	
7-38	1311-1313	an	*[1]	_	
7-39	1314-1316	IV	*[1]	_	
7-40	1317-1319	on	*[1]	_	
7-41	1320-1324	many	*[1]	_	
7-42	1325-1333	patients	*[1]	_	
7-43	1333-1334	,	*[1]	_	
7-44	1335-1342	doctors	*[1]	_	
7-45	1342-1343	,	*[1]	_	
7-46	1344-1350	nurses	*[1]	_	
7-47	1351-1354	and	*[1]	_	
7-48	1355-1365	paramedics	*[1]	_	
7-49	1366-1371	often	*[1]	_	
7-50	1372-1382	experience	*[1]	_	
7-51	1383-1388	great	*[1]	_	
7-52	1389-1399	difficulty	*[1]	_	
7-53	1400-1412	establishing	*[1]	_	
7-54	1413-1415	IV	*[1]	_	
7-55	1416-1422	access	*[1]	_	
7-56	1423-1425	in	*[1]	_	
7-57	1426-1430	some	*[1]	_	
7-58	1431-1439	patients	*[1]	_	
7-59	1439-1440	.	*[1]	_	

#Text=These patients are probed repeatedly with sharp needles in an attempt to solve this problem and may require an invasive procedure to finally establish an intravenous route.
8-1	1441-1446	These	_	_	
8-2	1447-1455	patients	_	_	
8-3	1456-1459	are	_	_	
8-4	1460-1466	probed	_	_	
8-5	1467-1477	repeatedly	_	_	
8-6	1478-1482	with	_	_	
8-7	1483-1488	sharp	_	_	
8-8	1489-1496	needles	_	_	
8-9	1497-1499	in	_	_	
8-10	1500-1502	an	_	_	
8-11	1503-1510	attempt	_	_	
8-12	1511-1513	to	_	_	
8-13	1514-1519	solve	_	_	
8-14	1520-1524	this	*[2]	_	
8-15	1525-1532	problem	*[2]	_	
8-16	1533-1536	and	_	_	
8-17	1537-1540	may	_	_	
8-18	1541-1548	require	_	_	
8-19	1549-1551	an	_	_	
8-20	1552-1560	invasive	_	_	
8-21	1561-1570	procedure	_	_	
8-22	1571-1573	to	_	_	
8-23	1574-1581	finally	_	_	
8-24	1582-1591	establish	_	_	
8-25	1592-1594	an	_	_	
8-26	1595-1606	intravenous	_	_	
8-27	1607-1612	route	_	_	
8-28	1612-1613	.	_	_	

#Text=A further complicating factor in achieving IV access occurs "in the field" (e.g., at the scene of an accident or during ambulance transport) where it is difficult to see the target and/or excessive motion makes accessing the venous system very difficult.
#Text=[0009]In the case of some patients (e.g., those with chronic disease or the elderly), the availability of easily-accessible veins may be depleted.
9-1	1614-1615	A	_	_	
9-2	1616-1623	further	_	_	
9-3	1624-1636	complicating	_	_	
9-4	1637-1643	factor	_	_	
9-5	1644-1646	in	_	_	
9-6	1647-1656	achieving	_	_	
9-7	1657-1659	IV	_	_	
9-8	1660-1666	access	_	_	
9-9	1667-1673	occurs	_	_	
9-10	1674-1675	"	_	_	
9-11	1675-1677	in	_	_	
9-12	1678-1681	the	_	_	
9-13	1682-1687	field	_	_	
9-14	1687-1688	"	_	_	
9-15	1689-1690	(	_	_	
9-16	1690-1693	e.g	_	_	
9-17	1693-1694	.	_	_	
9-18	1694-1695	,	_	_	
9-19	1696-1698	at	_	_	
9-20	1699-1702	the	_	_	
9-21	1703-1708	scene	_	_	
9-22	1709-1711	of	_	_	
9-23	1712-1714	an	_	_	
9-24	1715-1723	accident	_	_	
9-25	1724-1726	or	_	_	
9-26	1727-1733	during	_	_	
9-27	1734-1743	ambulance	_	_	
9-28	1744-1753	transport	_	_	
9-29	1753-1754	)	_	_	
9-30	1755-1760	where	_	_	
9-31	1761-1763	it	_	_	
9-32	1764-1766	is	_	_	
9-33	1767-1776	difficult	_	_	
9-34	1777-1779	to	_	_	
9-35	1780-1783	see	_	_	
9-36	1784-1787	the	_	_	
9-37	1788-1794	target	_	_	
9-38	1795-1798	and	_	_	
9-39	1798-1799	/	_	_	
9-40	1799-1801	or	_	_	
9-41	1802-1811	excessive	_	_	
9-42	1812-1818	motion	_	_	
9-43	1819-1824	makes	_	_	
9-44	1825-1834	accessing	_	_	
9-45	1835-1838	the	_	_	
9-46	1839-1845	venous	_	_	
9-47	1846-1852	system	_	_	
9-48	1853-1857	very	_	_	
9-49	1858-1867	difficult	_	_	
9-50	1867-1868	.	_	_	
9-51	1869-1870	[	_	_	
9-52	1870-1874	0009	_	_	
9-53	1874-1875	]	_	_	
9-54	1875-1877	In	_	_	
9-55	1878-1881	the	_	_	
9-56	1882-1886	case	_	_	
9-57	1887-1889	of	_	_	
9-58	1890-1894	some	_	_	
9-59	1895-1903	patients	_	_	
9-60	1904-1905	(	_	_	
9-61	1905-1908	e.g	_	_	
9-62	1908-1909	.	_	_	
9-63	1909-1910	,	_	_	
9-64	1911-1916	those	_	_	
9-65	1917-1921	with	_	_	
9-66	1922-1929	chronic	_	_	
9-67	1930-1937	disease	_	_	
9-68	1938-1940	or	_	_	
9-69	1941-1944	the	_	_	
9-70	1945-1952	elderly	_	_	
9-71	1952-1953	)	_	_	
9-72	1953-1954	,	_	_	
9-73	1955-1958	the	_	_	
9-74	1959-1971	availability	_	_	
9-75	1972-1974	of	_	_	
9-76	1975-1992	easily-accessible	_	_	
9-77	1993-1998	veins	_	_	
9-78	1999-2002	may	_	_	
9-79	2003-2005	be	_	_	
9-80	2006-2014	depleted	_	_	
9-81	2014-2015	.	_	_	

#Text=Other patients may have no available IV sites due to anatomical scarcity of peripheral veins, obesity, extreme dehydration, and/or previous IV drug use.
10-1	2016-2021	Other	_	_	
10-2	2022-2030	patients	_	_	
10-3	2031-2034	may	_	_	
10-4	2035-2039	have	_	_	
10-5	2040-2042	no	_	_	
10-6	2043-2052	available	_	_	
10-7	2053-2055	IV	_	_	
10-8	2056-2061	sites	_	_	
10-9	2062-2065	due	_	_	
10-10	2066-2068	to	_	_	
10-11	2069-2079	anatomical	_	_	
10-12	2080-2088	scarcity	_	_	
10-13	2089-2091	of	_	_	
10-14	2092-2102	peripheral	_	_	
10-15	2103-2108	veins	_	_	
10-16	2108-2109	,	_	_	
10-17	2110-2117	obesity	_	_	
10-18	2117-2118	,	_	_	
10-19	2119-2126	extreme	_	_	
10-20	2127-2138	dehydration	_	_	
10-21	2138-2139	,	_	_	
10-22	2140-2143	and	_	_	
10-23	2143-2144	/	_	_	
10-24	2144-2146	or	_	_	
10-25	2147-2155	previous	_	_	
10-26	2156-2158	IV	_	_	
10-27	2159-2163	drug	_	_	
10-28	2164-2167	use	_	_	
10-29	2167-2168	.	_	_	

#Text=For these patients, finding a suitable site for administering lifesaving drugs becomes a monumental and frustrating task.
11-1	2169-2172	For	_	_	
11-2	2173-2178	these	_	_	
11-3	2179-2187	patients	_	_	
11-4	2187-2188	,	_	_	
11-5	2189-2196	finding	_	_	
11-6	2197-2198	a	_	_	
11-7	2199-2207	suitable	_	_	
11-8	2208-2212	site	_	_	
11-9	2213-2216	for	_	_	
11-10	2217-2230	administering	_	_	
11-11	2231-2241	lifesaving	_	_	
11-12	2242-2247	drugs	_	_	
11-13	2248-2255	becomes	_	_	
11-14	2256-2257	a	_	_	
11-15	2258-2268	monumental	_	_	
11-16	2269-2272	and	_	_	
11-17	2273-2284	frustrating	_	_	
11-18	2285-2289	task	_	_	
11-19	2289-2290	.	_	_	

#Text=While morbidity and mortality statistics are not generally available, it is known that many patients with life-threatening emergencies have died of ensuing complications because access to the vascular system with life-saving IV therapy was delayed or simply not possible.
12-1	2291-2296	While	_	_	
12-2	2297-2306	morbidity	_	_	
12-3	2307-2310	and	_	_	
12-4	2311-2320	mortality	_	_	
12-5	2321-2331	statistics	_	_	
12-6	2332-2335	are	_	_	
12-7	2336-2339	not	_	_	
12-8	2340-2349	generally	_	_	
12-9	2350-2359	available	_	_	
12-10	2359-2360	,	_	_	
12-11	2361-2363	it	_	_	
12-12	2364-2366	is	_	_	
12-13	2367-2372	known	_	_	
12-14	2373-2377	that	_	_	
12-15	2378-2382	many	_	_	
12-16	2383-2391	patients	_	_	
12-17	2392-2396	with	_	_	
12-18	2397-2413	life-threatening	_	_	
12-19	2414-2425	emergencies	_	_	
12-20	2426-2430	have	_	_	
12-21	2431-2435	died	_	_	
12-22	2436-2438	of	_	_	
12-23	2439-2446	ensuing	_	_	
12-24	2447-2460	complications	_	_	
12-25	2461-2468	because	_	_	
12-26	2469-2475	access	_	_	
12-27	2476-2478	to	_	_	
12-28	2479-2482	the	_	_	
12-29	2483-2491	vascular	_	_	
12-30	2492-2498	system	_	_	
12-31	2499-2503	with	_	_	
12-32	2504-2515	life-saving	_	_	
12-33	2516-2518	IV	_	_	
12-34	2519-2526	therapy	_	_	
12-35	2527-2530	was	_	_	
12-36	2531-2538	delayed	_	_	
12-37	2539-2541	or	_	_	
12-38	2542-2548	simply	_	_	
12-39	2549-2552	not	_	_	
12-40	2553-2561	possible	_	_	
12-41	2561-2562	.	_	_	

#Text=For such patients, an alternative approach is required.
#Text=[0010]Powered drivers associated with intraosseous (IO) devices typically include a housing with various types of motors and/or gear assemblies disposed therein.
13-1	2563-2566	For	_	_	
13-2	2567-2571	such	_	_	
13-3	2572-2580	patients	_	_	
13-4	2580-2581	,	_	_	
13-5	2582-2584	an	_	_	
13-6	2585-2596	alternative	_	_	
13-7	2597-2605	approach	_	_	
13-8	2606-2608	is	_	_	
13-9	2609-2617	required	_	_	
13-10	2617-2618	.	_	_	
13-11	2619-2620	[	_	_	
13-12	2620-2624	0010	_	_	
13-13	2624-2625	]	_	_	
13-14	2625-2632	Powered	_	_	
13-15	2633-2640	drivers	_	_	
13-16	2641-2651	associated	_	_	
13-17	2652-2656	with	_	_	
13-18	2657-2669	intraosseous	_	_	
13-19	2670-2671	(	_	_	
13-20	2671-2673	IO	_	_	
13-21	2673-2674	)	_	_	
13-22	2675-2682	devices	_	_	
13-23	2683-2692	typically	_	_	
13-24	2693-2700	include	_	_	
13-25	2701-2702	a	_	_	
13-26	2703-2710	housing	_	_	
13-27	2711-2715	with	_	_	
13-28	2716-2723	various	_	_	
13-29	2724-2729	types	_	_	
13-30	2730-2732	of	_	_	
13-31	2733-2739	motors	_	_	
13-32	2740-2743	and	_	_	
13-33	2743-2744	/	_	_	
13-34	2744-2746	or	_	_	
13-35	2747-2751	gear	_	_	
13-36	2752-2762	assemblies	_	_	
13-37	2763-2771	disposed	_	_	
13-38	2772-2779	therein	_	_	
13-39	2779-2780	.	_	_	

#Text=A rotatable shaft may be disposed within the housing and connected with a gear assembly.
14-1	2781-2782	A	_	_	
14-2	2783-2792	rotatable	_	_	
14-3	2793-2798	shaft	_	_	
14-4	2799-2802	may	_	_	
14-5	2803-2805	be	_	_	
14-6	2806-2814	disposed	_	_	
14-7	2815-2821	within	_	_	
14-8	2822-2825	the	_	_	
14-9	2826-2833	housing	_	_	
14-10	2834-2837	and	_	_	
14-11	2838-2847	connected	_	_	
14-12	2848-2852	with	_	_	
14-13	2853-2854	a	_	_	
14-14	2855-2859	gear	_	_	
14-15	2860-2868	assembly	_	_	
14-16	2868-2869	.	_	_	

#Text=Various types of fittings, connections, connectors and/or connector receptacles may be provided at one end of the rotatable shaft extending from the housing to releasably engage an IO device with the powered driver.
15-1	2870-2877	Various	_	_	
15-2	2878-2883	types	_	_	
15-3	2884-2886	of	_	_	
15-4	2887-2895	fittings	_	_	
15-5	2895-2896	,	_	_	
15-6	2897-2908	connections	_	_	
15-7	2908-2909	,	_	_	
15-8	2910-2920	connectors	_	_	
15-9	2921-2924	and	_	_	
15-10	2924-2925	/	_	_	
15-11	2925-2927	or	_	_	
15-12	2928-2937	connector	_	_	
15-13	2938-2949	receptacles	_	_	
15-14	2950-2953	may	_	_	
15-15	2954-2956	be	_	_	
15-16	2957-2965	provided	_	_	
15-17	2966-2968	at	_	_	
15-18	2969-2972	one	_	_	
15-19	2973-2976	end	_	_	
15-20	2977-2979	of	_	_	
15-21	2980-2983	the	_	_	
15-22	2984-2993	rotatable	_	_	
15-23	2994-2999	shaft	_	_	
15-24	3000-3009	extending	_	_	
15-25	3010-3014	from	_	_	
15-26	3015-3018	the	_	_	
15-27	3019-3026	housing	_	_	
15-28	3027-3029	to	_	_	
15-29	3030-3040	releasably	_	_	
15-30	3041-3047	engage	_	_	
15-31	3048-3050	an	_	_	
15-32	3051-3053	IO	_	_	
15-33	3054-3060	device	_	_	
15-34	3061-3065	with	_	_	
15-35	3066-3069	the	_	_	
15-36	3070-3077	powered	_	_	
15-37	3078-3084	driver	_	_	
15-38	3084-3085	.	_	_	
